Redsense Medical ABRDSNF -51.43%54 PB Ratio is 2.22 as of Jun. 27, 2026, which is 58% below its 10-year median of 5.24. GuruFocus rates RDSNF with a GF Score™ of 54/100 and a GF Value™ of $0.85. The stock has 5 warning signs investors should review. Among 788 Medical Devices & Instruments companies, Redsense Medical AB ranks better than 53.93% on this metric.
The historical rank and industry rank for Redsense Medical AB's PB Ratio or its related term are showing as below:
RDSNF'
s PB Ratio Range Over the Past 10 Years
Min: 1.21 Med: 5.24 Max: 105.89
Current: 1.89
During the past 13 years, Redsense Medical AB's highest PB Ratio was 105.89. The lowest was 1.21. And the median was 5.24.
RDSNF's PB Ratio is ranked better than 53.93% of 788
companies
in the Medical Devices & Instruments industry
Industry Median: 2.02
vs RDSNF: 1.89
During the past 12 months, Redsense Medical AB's average Book Value Per Share Growth Rate was -6.00% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 2.50% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -13.50% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 36.40% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Redsense Medical AB was 156.80% per year. The lowest was -31.90% per year. And the median was 24.25% per year.
Back to Basics: PB Ratio
Redsense Medical AB (OTCPK:RDSNF) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Redsense Medical AB PB Ratio Related Terms
Redsense Medical AB PB Ratio Historical Data
* Premium members only.
The historical data trend for Redsense Medical AB's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Redsense Medical AB's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Redsense Medical AB PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Redsense Medical AB's PB Ratio distribution charts can be found below:
* The bar in red indicates where Redsense Medical AB's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Redsense Medical AB (RDSNF) has a PB Ratio of 2.22 as of Jun. 27, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Redsense Medical AB and its competitors. This is 58% below median its historical median of 5.24. Over the past decade, Redsense Medical AB's PB Ratio has ranged from 1.21 to 105.89. According to the industry distribution chart, Redsense Medical AB ranks #363 out of 788 companies in the Medical Devices & Instruments industry, placing it in the top 46.1%.
Is Redsense Medical AB's PB Ratio too high?
Redsense Medical AB's current PB Ratio of 2.22 is 58% below median its 10-year median of 5.24. Over the past 10 years, this metric has ranged from a low of 1.21 to a high of 105.89. The Medical Devices & Instruments industry median PB Ratio is 2.02. Redsense Medical AB's value of 2.22 is 9.9% above this industry median. Based on the distribution chart, Redsense Medical AB ranks #363 out of 788 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Redsense Medical AB has a GF Score™ of 54/100, reflecting its overall financial health beyond just this single metric.
How does Redsense Medical AB's PB Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Redsense Medical AB ranks #363 out of 788 companies for PB Ratio. This puts Redsense Medical AB in the upper half of its industry. The industry median PB Ratio is 2.02. Redsense Medical AB's value of 2.22 is 9.9% above this benchmark. Historically, Redsense Medical AB's own PB Ratio has ranged from 1.21 to 105.89 over the past decade. While the company's 10-year median is 5.24 vs. the industry median of 2.02, Redsense Medical AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.02, based on 788 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Redsense Medical AB's current PB Ratio of 2.22 is 9.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Redsense Medical AB and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Redsense Medical AB's current PB Ratio is 2.22, which is 58% below median its own 10-year median of 5.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Redsense Medical AB stock overvalued right now?
Redsense Medical AB (RDSNF) has a current PB Ratio of 2.22. The stock's GF Value™ is $0.85, compared to a current price of $0.51 — trading 40% below its estimated fair value. The current PB Ratio is 2.22, which is 58% below median its 10-year median of 5.24 and 9.9% above the Medical Devices & Instruments industry median of 2.02. Redsense Medical AB's overall GF Score™ is 54/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Redsense Medical AB (RDSNF), the current PB Ratio is 2.22 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Redsense Medical AB (RDSNF) Overvalued in 2026?
Based on GuruFocus' analysis, Redsense Medical AB stock appears to be undervalued.
The current stock price of $0.51 is trading 40% below its estimated GF Value™ of $0.85.
Key valuation signals for RDSNF:
PB Ratio: 2.22 (58% below median its 10-year median of 5.24)
GF Value™: $0.85 vs. price of $0.51 (40% below fair value)
Industry Position: 9.9% above the Medical Devices & Instruments median (#363 of 788)
No single metric tells the full story. See the RDSNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Redsense Medical AB manufactures and sells blood loss detection devices in Sweden. The company has developed a monitoring system that can detect the first sign of a blood leak using patented fiber optic technology. The products of the company include Alarm Unit, Venous Needle Patch, Sensor Patch, and others.
54GF Score
Get the complete analysis for RDSNF
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RDSNF has been successfully added to your 
